KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Neogenomics (NEO) Return on Invested Capital: 2014-2025

Historic Return on Invested Capital for Neogenomics (NEO) over the last 7 years, with Sep 2025 value amounting to -0.14%.

  • Neogenomics' Return on Invested Capital fell 4.00% to -0.14% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.14%, marking a year-over-year decrease of 4.00%. This contributed to the annual value of -0.10% for FY2024, which is negligibly% changed negligibly from last year.
  • Per Neogenomics' latest filing, its Return on Invested Capital stood at -0.14% for Q3 2025, which was down 9.12% from -0.13% recorded in Q2 2025.
  • Neogenomics' Return on Invested Capital's 5-year high stood at -0.01% during Q1 2021, with a 5-year trough of -0.15% in Q3 2022.
  • Over the past 3 years, Neogenomics' median Return on Invested Capital value was -0.10% (recorded in 2023), while the average stood at -0.11%.
  • In the last 5 years, Neogenomics' Return on Invested Capital fell by 10bps in 2022 and then rose by 5bps in 2023.
  • Neogenomics' Return on Invested Capital (Quarterly) stood at -0.06% in 2021, then fell by 8bps to -0.14% in 2022, then grew by 4bps to -0.10% in 2023, then remained steady at -0.10% in 2024, then declined by 4bps to -0.14% in 2025.
  • Its last three reported values are -0.14% in Q3 2025, -0.13% for Q2 2025, and -0.10% during Q1 2025.